000 01190 a2200325 4500
005 20250516094043.0
264 0 _c20130801
008 201308s 0 0 eng d
022 _a1873-4294
024 7 _a10.2174/156802612801784407
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKumar, Neeraj
245 0 0 _aThalidomide: chemistry, therapeutic potential and oxidative stress induced teratogenicity.
_h[electronic resource]
260 _bCurrent topics in medicinal chemistry
_c2012
300 _a1436-55 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMultiple Myeloma
_xdrug therapy
650 0 4 _aOxidative Stress
_xdrug effects
650 0 4 _aTeratogens
_xchemistry
650 0 4 _aThalidomide
_xadverse effects
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aSharma, Upendra
700 1 _aSingh, Chitra
700 1 _aSingh, Bikram
773 0 _tCurrent topics in medicinal chemistry
_gvol. 12
_gno. 13
_gp. 1436-55
856 4 0 _uhttps://doi.org/10.2174/156802612801784407
_zAvailable from publisher's website
999 _c21825331
_d21825331